FluoGuide A/S

SSE:FLUO.ST

55.6 (SEK) • At close February 20, 2024
Bedrijfsnaam FluoGuide A/S
Symbool FLUO.ST
Munteenheid SEK
Prijs 55.6
Beurswaarde 678,214,360
Dividendpercentage 0%
52-weken bereik 52.6 - 119.8
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Morten Albrechtsen B.B.A., M.D., BBA
Website https://fluoguide.com

An error occurred while fetching data.

Over FluoGuide A/S

FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also

Vergelijkbare Aandelen

Oncopeptides AB (publ) logo

Oncopeptides AB (publ)

ONCO.ST

7.264 SEK

InDex Pharmaceuticals Holding AB (publ) logo

InDex Pharmaceuticals Holding AB (publ)

INDEX.ST

0.244 SEK

Stille AB logo

Stille AB

STIL.ST

160.5 SEK

Episurf Medical AB (publ) logo

Episurf Medical AB (publ)

EPIS-B.ST

0.98 SEK

Egetis Therapeutics AB (publ) logo

Egetis Therapeutics AB (publ)

EGTX.ST

6.07 SEK

Bio-Works Technologies AB (publ) logo

Bio-Works Technologies AB (publ)

BIOWKS.ST

4.85 SEK

Enzymatica AB (publ) logo

Enzymatica AB (publ)

ENZY.ST

3.05 SEK

Karolinska Development AB (publ) logo

Karolinska Development AB (publ)

KDEV.ST

1.65 SEK

Boule Diagnostics AB (publ) logo

Boule Diagnostics AB (publ)

BOUL.ST

9.36 SEK

Financiële Gegevens

Cijfers zijn in miljoenen (SEK)

Cijfers zijn in miljoenen (SEK)